1
|
Esplin ED, Chittenden AB, Stopfer J, Schneider K, Sacca R, Stickevers S, Kipnis L, Koeller DR, Gaonkar S, Sotelo J, Espinel W, Champine M, Westman J, Brock P, Shane-Carson KP, Pearlman R, Pilarski R, Sweet K, Jeter JM, Hampel H. Beyond BRCA1/2: Clinician-reported utility 3 years post panel testing. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.e18705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | - Marjan Champine
- Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
| | | | - Pamela Brock
- Division of Endocrinology and Metabolism, The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | | | | | - Robert Pilarski
- Division of Human Genetics and The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | | | | | - Heather Hampel
- The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | | |
Collapse
|